New Delhi : Bharat Biotech’s Covid-19 vaccine Covaxin secured approval from the Drugs Controller General of India
(DCGI) on Tuesday for use on children above 2 years of age in a major boost to the country’s fight against the pandemic.
Covaxin will be the first Covid-19 vaccine in the country to be administered to those below 18 years of age.
The Subject Expert Committee (SEC) for Covid-19 drugs under Central Drugs Control Standard Organisation (CDSCO) earlier recommended the Covaxin in two-dose regimen to be given at a gap of 28 days as primer and booster shots.
More Stories
Box Office: Sunny Deol’s Jaat Crosses 50 Crore Mark
Mayank Yadav joins LSG of IPL 2025
India’s Tour of England will be a Good Challenge for Us